logo-ULB lymphes UNITE DE RECHERCHE
EN LYMPHOLOGIE

Jean-Paul Belgrado, coordinateur
Liesbeth Vandermeeren - Léonore Bruetschy
Camilo Garcia - Jean-Jacques Moraine
Jean-Baptiste Valsamis - Véronique Fuchs
Kevin Dusart

 

 

Protocol of a Randomised Controlled Trial regarding the Effectiveness of Fluoroscopy-guided Manual Lymph Drainage for the Treatment of Breast Cancer-Related Lymphoedema (EFforT-BCRL Trial)

Article in European Journal of Obstetrics and Gynecology (EURO10154), sciencedirect.com · 16 December 2017

Tessa De Vrieze
Lore Vos
Nick Gebruers
Wiebren A.A. Tjalma
Sarah Thomis
Patrick Neven
Ines Nevelsteen
An De Groef
Liesbeth Vandermeeren
Jean-Paul Belgrado
Nele Devoogdt

Abstract

Objectives

Lymphoedema is a dreadful complication following breast cancer therapy. According to the International Society of Lymphology, the consensus treatment for breast cancer-related lymphoedema (BCRL) is the decongestive lymphatic therapy. This is a two-phase treatment and combines different treatment modalities including skin care, manual lymphatic drainage (MLD), compression therapy and exercise. However, the additional effect of MLD is debated since pooled data only demonstrated a limited non-significant additional value. A possible explanation is that in previous studies MLD has been applied blind, without knowledge of patient-specific lymphatic routes of transport. In addition, the MLD hand manoeuvres used by the therapists in previous studies, possibly did not optimally stimulate lymphatic transport. Recently, near-infrared fluorescence imaging has been introduced to visualise the superficial lymphatic network which allows MLD at the most needed location. The aim of the present study is to determine the effectiveness of the fluoroscopy-guided MLD, additional to the other parts of the decongestive lymphatic therapy and compared to the traditional or a placebo MLD, in the treatment of BCRL.

Study design

A three-arm double-blinded randomised controlled trial will be conducted in different university hospitals in Belgium. Based on a sample size calculation, 201 participants with chronic BCRL stage 1 or 2 of the arm or hand, with at least 5% difference between both sides (corrected for hand dominance) need to be recruited. All participants receive the standard treatment: skin care, compression therapy and exercises. The intervention group additionally receives fluoroscopy-guided MLD. One control group additionally receives the traditional ‘blind’ MLD and a second control group receives a placebo MLD. All subjects receive 3 weeks of daily intensive treatments and 6 months of maintenance treatment. Follow-up period is 6 months. The primary outcomes are the reduction in lymphoedema volume of the arm/hand and the change in stagnation of lymph fluid at level of the shoulder/trunk.

Link

www.sciencedirect.com/science/article/pii/S0301211517305729

Paramétrages de cookies

×

Cookies fonctionnels

Ce site utilise des cookies pour assurer son bon fonctionnement et ne peuvent pas être désactivés de nos systèmes. Nous ne les utilisons pas à des fins publicitaires. Si ces cookies sont bloqués, certaines parties du site ne pourront pas fonctionner.

Mesure d'audience

Ce site utilise des cookies de mesure et d’analyse d’audience, tels que Google Analytics et Google Ads, afin d’évaluer et d’améliorer notre site internet.

    Contenus interactifs

    Ce site utilise des composants tiers, tels que ReCAPTCHA, Google Maps, MailChimp ou Calameo, qui peuvent déposer des cookies sur votre machine. Si vous décider de bloquer un composant, le contenu ne s’affichera pas

    Réseaux sociaux/Vidéos

    Des plug-ins de réseaux sociaux et de vidéos, qui exploitent des cookies, sont présents sur ce site web. Ils permettent d’améliorer la convivialité et la promotion du site grâce à différentes interactions sociales.

    Autres cookies

    Nous utilisons un certain nombre de cookies pour gérer par exemple les sessions utilisateurs.

    Activation

    Fields cannot be empty

    Log in